Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Moat Ross exercised options for 8,285 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Moat Ross (CHIEF OPERATING OFFICER) exercised options for 8,285 Kiniksa Pharmaceuticals International, Plc shares, leaving 16,307 shares. Filed Sep 3, 2026 (Form 4).
- Options exercised
- 8,285 shares
- Holding after
- 16,307 shares
- Trading plan
- No
- Role
- CHIEF OPERATING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Class A Ordinary Share | Option exercise | 2,477 | 14,506 | Direct | |
| Sep 1, 2026 | Class A Ordinary Share | Option exercise | 1,611 | 16,117 | Direct | |
| Sep 1, 2026 | Class A Ordinary Share | Option exercise | 1,740 | 17,857 | Direct | |
| Sep 1, 2026 | Class A Ordinary Share | Option exercise | 2,457 | 20,314 | Direct | |
| Sep 1, 2026 | Class A Ordinary Share | Shares withheld for tax | 4,007 | US$79.28 | 16,307 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Moat Ross
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Moat Ross · Apr 13, 2026
- Form 4 · Moat Ross · Apr 8, 2026
- Form 4 · Moat Ross · Apr 3, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026